拜卡莱因向MAPK9,诱导肝细胞癌细胞的亡
Weili Wang1,2,3, Yuxiao Tang2, Xiaobin Zhuo4
1Jiangxi University of Chinese Medicine, Nanchang, China.
Chemical biology & drug design
|September 16, 2024
概括
拜卡莱因是一种天然化合物,通过直接向MAPK9.9,诱导肝细胞癌 (HCC) 的亡. 这一发现为HCC治疗提供了潜在的新疗法策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 肝细胞癌 (HCC) 是一个重大的全球健康挑战,有效的治疗选择有限.
- 自然产品正在越来越多地探索它们在HCC管理中的治疗潜力.
- 一种黄类化合物贝卡莱因具有抗瘤特性,但其在HCC中的直接分子标仍未确定.
研究的目的:
- 通过使用DNA编程的亲和力标记方法来识别baicalein的直接结合标.
- 为了验证已识别的点在baicalein介导肝细胞癌细胞亡中的功能性作用.
- 阐明贝卡莱因抗HCC活性背后的分子机制.
主要方法:
- 用DNA编程的亲和度标签被用来识别baicalein的结合伙伴.
- 使用表面等离子体共振 (SPR) 来量化贝卡莱因与其标之间的结合亲和力.
- 进行了虚拟对接,以分析绑定站点.
- 使用MAPK9抑制剂 (SP600125) 进行了功能性测试,以验证其作用机制.
主要成果:
- 拜卡莱因确定了136个具有约束力的标,其中13个在HCC组织中表达不同.
- 蛋白质激酶MAP激酶9 (MAPK9) 被确定为 Baicalein 的直接标.
- 拜卡莱因与MAPK9结合,增强了MAPK9水平和下游亡信号,诱导HCC细胞死亡.
- 抑制MAPK9阻断了拜卡莱因诱导的亡,证实了目标的作用.
结论:
- 在肝细胞癌中,MAPK9被确定为 Baicalein 的直接分子标.
- 拜卡莱因通过MAPK9信号通路诱导HCC细胞的亡.
- 这一发现为贝卡莱因在HCC治疗中的治疗潜力提供了机制基础.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
357
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
341
相关概念视频
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
